Chart pattern: Triple Top (weekly)
▼ Broken down
Broke on Nov 06, 2026 · measured target $53.42 (-14%). Details →
Nov 4, 4:19 PM ET
Ingevity reported third-quarter 2026 results, with net sales down 8% to $305.1 million, mainly because of the April 15, 2026 sale of the Road Markings product line. Net income from continuing operations rose to $51.1 million, or $1.46 per diluted share, from $40.8 million, or $1.10, a year earlier. The company narrowed its full-year adjusted EBITDA outlook to $385 million to $395 million while keeping the midpoint of the prior range, and said the timing of an Advanced Polymer Technologies sale agreement may extend into early 2027.
- Net sales of $305.1 million fell 8%; excluding Road Markings, sales rose 2%.
- Net income from continuing operations was $51.1 million, or $1.46 per diluted share, versus $1.10 a year earlier.
- Adjusted EBITDA was $108.0 million, down $2.4 million; full-year adjusted EBITDA outlook narrowed to $385 million to $395 million.
- Management said the timing of an Advanced Polymer Technologies sale agreement may extend into early 2027.
Read the filing on SEC.gov ↗
Jul 29, 5:18 PM ET
Ingevity reported second quarter 2026 net sales of $314.1 million, down 5% mainly because of the April 15, 2026 sale of its Road Markings product line, and up 5% excluding that line. Net income from continuing operations was $39.8 million, or $1.13 per diluted share, compared with a loss of $(141.4) million, or $(3.87) per share, a year earlier, and the company raised its full-year 2026 adjusted EBITDA and adjusted EPS guidance.
- Q2 adjusted EBITDA from continuing operations rose 14% to $115.0 million; adjusted EBITDA margin was 36.6% versus 30.5% a year earlier
- Q2 adjusted diluted EPS was $1.74, compared with $1.22 in the prior year
- Full-year 2026 adjusted EBITDA outlook raised to $380 million to $400 million; diluted adjusted EPS expected at $5.00 to $5.45
- Q2 operating cash flow was negative $15.8 million, including a $113.2 million litigation settlement payment; share repurchases totaled about $35 million in the quarter
Read the filing on SEC.gov ↗
Jun 24, 4:50 PM ET
Ingevity appointed Ryan Cotterman as Vice President, Chief Accounting Officer and principal accounting officer on June 22, 2026. He previously served as Senior Director, Corporate Controller at Ralliant Corporation and held controller and audit roles at Cornerstone Building Brands and Advance Auto Parts. The filing describes a routine finance leadership appointment with a disclosed compensation package.
- Base salary of $345,000, bonus target of 40% of base salary, and long-term incentive opportunity of 65% of base salary starting in 2027
- One-time sign-on cash bonus of $40,000 and restricted stock units with a grant date target value of $150,000, vesting over three years
- Cotterman previously spent 14 years at Ernst & Young LLP and is a licensed Certified Public Accountant in North Carolina
Read the filing on SEC.gov ↗
May 6, 4:35 PM ET
Ingevity reported first-quarter 2026 net sales of $258.0 million, up 4% from the prior year, while net income from continuing operations fell to $23.4 million, or $0.65 per diluted share, from $29.1 million and $0.79. The results include a $16.2 million litigation charge tied to legal fees payable to BASF, and the company reaffirmed its full-year 2026 guidance, adjusted for the Road Markings divestiture.
- Net sales were $258.0 million, up 4% from $247.9 million, driven mainly by pricing actions and favorable foreign exchange.
- Diluted EPS from continuing operations was $0.65 versus $0.79; the period included a $16.2 million litigation charge.
- Adjusted diluted EPS was $1.15 versus $1.01, and adjusted EBITDA was $91.5 million, flat year over year.
- Full-year 2026 outlook: net sales of $1.05 billion to $1.15 billion, adjusted EBITDA of $370 million to $395 million, and adjusted EPS of $4.70 to $5.20.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.